Enforcement Report - Week of October 25, 2023
25 Oct 2023 //
FDA
Avet`s Generic Foscarnet Sodium Receives Approval in the U.S.
05 Jun 2023 //
FDA
Takeda’s LIVTENCITY Available for Certain Individuals Ages 12 Years and Older
02 Dec 2021 //
BUSINESSWIRE
Takeda’s LIVTENCITYTM Approved by FDA in CMV; & more
23 Nov 2021 //
BUSINESSWIRE
FDA`s ADAC unanimously backs Takeda`s drug for post-transplant cytomegalovirus
08 Oct 2021 //
ENDPTS
Phase 3 Trial Subgroup Analysis Across SOT Types Supports Efficacy of Maribavir
07 Jun 2021 //
PRESS RELEASE
Gland Pharma Ltd`s Generic Foscarnet Sodium Receives Approval In US
04 May 2021 //
FDA
Clinigen makes foray into Japan
18 Oct 2016 //
BIO SPECTRUM